Literature DB >> 22396835

The role of stereotactic radiosurgery in metastasis to the spine.

Seil Sohn1, Chun Kee Chung.   

Abstract

OBJECTIVE: The incidence and prevalence of spinal metastases are increasing, and although the role of radiation therapy in the treatment of metastatic tumors of the spine has been well established, the same cannot be said about the role of stereotactic radiosurgery. Herein, the authors present a systematic review regarding the value of spinal stereotactic radiosurgery in the management of spinal metastasis.
METHODS: A systematic literature search for stereotactic radiosurgery of spinal metastases was undertaken. Grades of Recommendation, Assessment, Development, and Education (GRADE) working group criteria was used to evaluate the qualities of study datasets.
RESULTS: Thirty-one studies met the study inclusion criteria. Twenty-three studies were of low quality, and 8 were of very low quality according to the GRADE criteria. Stereotactic radiosurgery was reported to be highly effective in reducing pain, regardless of prior treatment. The overall local control rate was approximately 90%. Additional asymptomatic lesions may be treated by stereotactic radiosurgery to avoid further irradiation of neural elements and further bone-marrow suppression. Stereotactic radiosurgery may be preferred in previously irradiated patients when considering the radiation tolerance of the spinal cord. Furthermore, residual tumors after surgery can be safely treated by stereotactic radiosurgery, which decreases the likelihood of repeat surgery and accompanying surgical morbidities. Encompassing one vertebral body above and below the involved vertebrae is unnecessary. Complications associated with stereotactic radiosurgery are generally self-limited and mild.
CONCLUSION: In the management of spinal metastasis, stereotactic radiosurgery appears to provide high rates of tumor control, regardless of histologic diagnosis, and can be used in previously irradiated patients. However, the quality of literature available on the subject is not sufficient.

Entities:  

Keywords:  Local control; Radiation therapy; Radiosurgery; Spinal metastasis; Spine surgery; Spine tumors

Year:  2012        PMID: 22396835      PMCID: PMC3291699          DOI: 10.3340/jkns.2012.51.1.1

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  43 in total

1.  Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Authors:  Samuel Ryu; Fang Fang Yin; Jack Rock; Jingeng Zhu; Archie Chu; Eduard Kagan; Lisa Rogers; Munther Ajlouni; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

2.  Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife robotic system.

Authors:  I C Gibbs
Journal:  Cancer Radiother       Date:  2006-07-21       Impact factor: 1.018

3.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations.

Authors:  Holger J Schünemann; Roman Jaeschke; Deborah J Cook; William F Bria; Ali A El-Solh; Armin Ernst; Bonnie F Fahy; Michael K Gould; Kathleen L Horan; Jerry A Krishnan; Constantine A Manthous; Janet R Maurer; Walter T McNicholas; Andrew D Oxman; Gordon Rubenfeld; Gerard M Turino; Gordon Guyatt
Journal:  Am J Respir Crit Care Med       Date:  2006-09-01       Impact factor: 21.405

4.  Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

Authors:  Peter C Gerszten; Steven A Burton; Cihat Ozhasoglu; William C Welch
Journal:  Spine (Phila Pa 1976)       Date:  2007-01-15       Impact factor: 3.468

Review 5.  Biology of chronic radiation effect on tissues and wound healing.

Authors:  E F Bernstein; F J Sullivan; J B Mitchell; G D Salomon; E Glatstein
Journal:  Clin Plast Surg       Date:  1993-07       Impact factor: 2.017

6.  Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis.

Authors:  Marsha L Haley; Peter C Gerszten; Dwight E Heron; Yue-Fang Chang; Dave S Atteberry; Steven A Burton
Journal:  J Neurosurg Spine       Date:  2011-02-11

7.  Factors influencing wound healing after surgery for metastatic disease of the spine.

Authors:  I B McPhee; R P Williams; C E Swanson
Journal:  Spine (Phila Pa 1976)       Date:  1998-03-15       Impact factor: 3.468

8.  Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery.

Authors:  Samuel Ryu; Jian-Yue Jin; Ryan Jin; Jack Rock; Munther Ajlouni; Benjamin Movsas; Mark Rosenblum; Jae Ho Kim
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

9.  Treatment of spinal tumors using cyberknife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients.

Authors:  Gregory J Gagnon; Nadim M Nasr; Jay J Liao; Inge Molzahn; David Marsh; Donald McRae; Fraser C Henderson
Journal:  Neurosurgery       Date:  2009-02       Impact factor: 4.654

Review 10.  Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy.

Authors:  Jason P Sheehan; Christopher I Shaffrey; David Schlesinger; Brian J Williams; Vincent Arlet; James Larner
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

View more
  13 in total

Review 1.  Review of stereotactic radiosurgery for intradural spine tumors.

Authors:  Taylor E Purvis; C Rory Goodwin; Daniel Lubelski; Ilya Laufer; Daniel M Sciubba
Journal:  CNS Oncol       Date:  2017-04

2.  Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study.

Authors:  Seil Sohn; Chun Kee Chung; Moon Jun Sohn; Ung-Kyu Chang; Sung Hwan Kim; Jinhee Kim; Eunjung Park
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

Review 3.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

4.  Survival-Related Factors of Spinal Metastasis with Hepatocellular Carcinoma in Current Surgical Treatment Modalities : A Single Institute Experience.

Authors:  Min Ho Lee; Sun-Ho Lee; Eun-Sang Kim; Whan Eoh; Sung-Soo Chung; Chong-Suh Lee
Journal:  J Korean Neurosurg Soc       Date:  2015-11-30

Review 5.  Review of stereotactic radiosurgery for intramedullary spinal lesions.

Authors:  Hyung-Ki Park; Jae-Chil Chang
Journal:  Korean J Spine       Date:  2013-03-31

6.  The failures and challenges of bone metastases research in radiation oncology.

Authors:  Gillian Bedard; Edward Chow
Journal:  J Bone Oncol       Date:  2013-04-22       Impact factor: 4.072

7.  Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009-2012.

Authors:  Seil Sohn; Jinhee Kim; Chun Kee Chung; Na-Rye Lee; Eunjung Park; Ung-Kyu Chang; Moon Jun Sohn; Sung Hwan Kim
Journal:  Neurooncol Pract       Date:  2015-05-05

8.  Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial.

Authors:  Pètra Braam; Philippe Lambin; Johan Bussink
Journal:  Trials       Date:  2016-02-02       Impact factor: 2.279

9.  Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases.

Authors:  Dorota Księżniak-Baran; Sławomir Blamek; Agata Roch-Zniszczoł; Małgorzata Stąpór-Fudzińska; Leszek Miszczyk
Journal:  Contemp Oncol (Pozn)       Date:  2015-08-07

10.  Radiosurgery Compared with External Radiation Therapy as a Primary Treatment in Spine Metastasis from Hepatocellular Carcinoma : A Multicenter, Matched-Pair Study.

Authors:  Seil Sohn; Chun Kee Chung; Moon Jun Sohn; Sung Hwan Kim; Jinhee Kim; Eunjung Park
Journal:  J Korean Neurosurg Soc       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.